March 18, 2018 10:07 AM ET


Company Overview of Akrimax Pharmaceuticals, LLC

Key Executives for Akrimax Pharmaceuticals, LLC

NameBoard RelationshipsTitleAge
Raymond Dean No RelationshipsPresident--
Joseph J. Krivulka 22 RelationshipsCo-Founder and Chairman65
Leonard L. Mazur 29 RelationshipsCo-Founder and Vice Chairman72
Keith F. Lavan No RelationshipsVice President of Financial Operations--
Timothy J. Soule No RelationshipsVice President of Operations--
View More Key Executives

Akrimax Pharmaceuticals, LLC Board Members*

NameBoard RelationshipsPrimary CompanyAge
Joseph J. Krivulka 22 RelationshipsAkrimax Pharmaceuticals, LLC65
Leonard L. Mazur 29 RelationshipsCitius Pharmaceuticals, Inc.72
View All Board Members

Akrimax Pharmaceuticals, LLC Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
Akrimax Pharmaceuticals, LLC CEO Compensation
Industry Average


Vivus, Inc. Announces Resignation of Allan L. Shaw from its Audit Committee and Compensation Committee
March 02, 2018 9:06 PM ET
Novartis AG Announces Retirement of Pierre Landolt from the Board of Directors
March 02, 2018 9:00 AM ET
Aurora Cannabis Inc. Appoints Shane Morris as Vice President Product Development and Regulatory Affairs and Kelly Narine as Vice President of Research
March 01, 2018 10:00 PM ET
Bristol-Myers Squibb Company Appoints Jose Baselga as Member of the Board of Directors
March 01, 2018 9:59 PM ET
Tetraphase Pharmaceuticals Promotes Larry Edwards Larry Edwards, Chief Commercial Officer, to Chief Operating Officer
March 01, 2018 9:01 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Akrimax Pharmaceuticals, LLC, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at